NCT00470457View on ClinicalTrials.gov

A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

March 31, 2005

Conditions
Rhinoconjunctivitis Due to Grass Pollen Allergy
Interventions
BIOLOGICAL

Allergen specific immunotherapy

Trial Locations (1)

Unknown

Clinic for Dermatology University Hospital of Zurich, Zurich

Sponsors

Collaborators (1)

AlleCure
All Listed Sponsors
collaborator

AlleCure

INDUSTRY

lead

University of Zurich

OTHER

NCT00470457 - A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy | Biotech Hunter | Biotech Hunter